The prenatal testing landscape continues to evolve. Scientific breakthroughs are expanding what's possible for patients, while consolidation across the genetic testing industry is reshaping the companies that deliver these services.
For healthcare providers, these changes raise an important question: What should you expect from a prenatal testing partner, not just today, but for years to come?
At BillionToOne, our answer has remained consistent since day one: breakthrough technology, broad patient access, and a sustainable commitment to supporting you and advancing prenatal care.
Driven by scientists. Shaped by clinicians to make innovation accessible.
When BillionToOne was founded, our goal wasn't simply to develop another prenatal screening test. We set out to solve some of the most challenging problems in genetic testing and make those advances accessible to as many patients as possible.
That philosophy shaped how we built Unity: highly accurate, cost-efficient technology designed to make advanced prenatal screening more affordable and accessible. We believe the best innovations should make prenatal care more accessible, not create additional barriers for patients.
Built for scale. Designed to last.
BillionToOne has grown into one of the largest women's health specialty laboratories in the United States, delivering more than 2 million test results to patients and their families since launch.
Today, Unity is contracted with every major insurance plan, and commercially insured patients pay less than $100 out of pocket on average. Our cost-efficient technology and disciplined approach to growth have also enabled us to build a profitable prenatal testing business—one that can sustainably reinvest in the next generation of maternal and fetal health innovations.
Innovation that keeps moving prenatal care forward
Our commitment is reflected in the continued evolution of Unity.
From pioneering fetal-risk assessment, independent of the timing and availability of partner results, to expanding single-gene NIPT across a panel of up to 130 genes, we’re continuing to advance what’s possible from a maternal blood sample.
Over the years, we’ve introduced first-of-its-kind fetal RhD and fetal antigen testing, as well as a breakthrough innovation with Unity Confirm, a noninvasive confirmatory testing option for eligible high-risk aneuploidy screening results for those patients who cannot or choose not to pursue diagnostic testing, or who want additional information while awaiting results.
Each advancement reflects our belief that prenatal testing should deliver more meaningful information while simplifying the experience for patients and providers.
Here to support you and the future of prenatal care
As the industry evolves, providers deserve a partner with the focus, financial sustainability and long-term commitment to keep supporting you and advancing care.
At BillionToOne, prenatal care isn't simply one part of a broader laboratory portfolio. It's where our company began, and it remains central to our mission.
We're not stepping away from prenatal care. We're investing in its future.
Take a fresh look at Unity.
Discover how our approach to prenatal testing can support your patients, simplify workflows, and help advance your prenatal screening program.